Compound 884
Identifiers
- Canonical SMILES:
Cc1nnc(o1)-c1nc(C2CCCCC2)n(c1-c1ccc(F)c(Cl)c1)-c1cccc(Cl)c1F
- InChi:
InChI=1S/C24H20Cl2F2N4O/c1-13-30-31-24(33-13)21-22(15-10-11-18(27)17(26)12-15)32(19-9-5-8-16(25)20(19)28)23(29-21)14-6-3-2-4-7-14/h5,8-12,14H,2-4,6-7H2,1H3
- InChiKey:
WSYHJRPECYYALB-UHFFFAOYSA-N
External links
67031670 |
CHEMBL3260817 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 8.10 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 488.10 g/mol | |||
HBA | 5 | |||
HBD | 0 | |||
HBA + HBD | 5 | |||
AlogP | 5.62 | |||
TPSA | 56.74 | |||
RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011023677 | 497 | MDM2 Q00987 |
|
Biochemical assay | Time-Resolved FRET | pIC50 (half maximal inhibitory concentration, -log10) | 8.10 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4758 | Azeliragon | DB12689 | |
0.4398 | LY-2584702 | DB12690 | |
0.4391 | Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB02388 | |
0.4317 | Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB03084 | |
0.4098 | Ralimetinib | DB11787 | |
0.4088 | 4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine | DB01761 | |
0.3992 | Losartan | DB00678 | |
0.3942 | Otenabant | DB11745 | |
0.3872 | Olmesartan | DB00275 | |
0.3864 | Selonsertib | DB14916 | |
0.3858 | Velpatasvir | DB11613 | |
0.3843 | Gluco-Phenylimidazole | DB02862 | |
0.3789 | N-6022 | DB12206 | |
0.3785 | 4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole | DB03980 | |
0.3737 | Atorvastatin | DB01076 |